Helicobacter pylori eradication: Current aspects

Helicobacter pylori eradication: Current aspects

The paper gives an update on the efficiency of Helicobacter pylori eradication. Triple therapy (a proton pump inhibitor + clarithromycin + amoxicillin) therapy is shown to hold top positions as first-line therapy for H. pylori eradication as before. The leading second-line therapy regimens are quadr...

Full description

Bibliographic Details
Main Authors: V V Tsukanov, O S Amel'chugova, N N Butorin, O V Tret'iakova, A V Vasiutin
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2013-02-01
Series:Терапевтический архив
Subjects:
eradication
helicobacter pylori
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31227
Description
Summary:The paper gives an update on the efficiency of Helicobacter pylori eradication. Triple therapy (a proton pump inhibitor + clarithromycin + amoxicillin) therapy is shown to hold top positions as first-line therapy for H. pylori eradication as before. The leading second-line therapy regimens are quadruple and 10-day triple schemes including levofloxacin. This point of view is supported by the Russian Gastroenterology Association. To reduce an increase in H. pylori resistance to clarithromycin, it is advisable to use Klacid (generic name: clarithromycin) in the eradication schemes.
ISSN:0040-3660
2309-5342

Similar Items